mTOR-driven neural circuit changes initiate an epileptogenic cascade

Candi L LaSarge1, Raymund Y K Pun1, Zhiqing Gu2

  • 1Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States; Center for Pediatric Neuroscience, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, United States.

Progress in Neurobiology
|December 14, 2020
PubMed

Insights

Somatic mutations in the mTOR pathway cause epilepsy. Varying the number of affected cells in a mouse model showed that more knockout cells led to generalized seizures and loss of interneurons.

Area of Science:

  • Neuroscience
  • Genetics
  • Epilepsy Research

Background:

  • Mutations in the mTOR pathway are a significant cause of epilepsy, often due to somatic mutations affecting variable numbers of neurons.
  • Understanding how the number of affected neurons influences epilepsy phenotype is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of variable knockout cell load on epilepsy phenotype.
  • To elucidate the relationship between mTOR pathway dysregulation and neuronal circuit abnormalities.

Main Methods:

  • Development of a novel mouse model with inducible Pten deletion in hippocampal granule cells (0-40% cell load).
  • In vivo electroencephalography (EEG) and behavioral seizure monitoring.
  • In vitro electrophysiological recordings in hippocampal slices to assess synaptic and circuit activity.

Main Results:

  • Low knockout cell loads induced focal seizures, while higher loads resulted in generalized seizures.
  • Generalized seizures correlated with the loss of local circuit interneurons.
  • Electrophysiological analysis revealed that increasing knockout cell load progressively altered network excitability, from reduced population spike thresholds to increased spontaneous excitatory postsynaptic currents and recurrent activity.

Conclusions:

  • The percentage of knockout cells is a critical determinant of epilepsy phenotype in mTORopathies.
  • Disease progression involves a spectrum from subclinical circuit dysfunction to severe electrobehavioral seizures with secondary neuronal population involvement.
  • This model provides valuable insights into the mechanisms underlying mTOR-related epilepsies and their variable clinical presentations.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
916